REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Formáid: Artigo
Teanga:Russo
Foilsithe: IRBIS LLC 2015-09-01
Sraith:Фармакоэкономика
Ábhair:
pharmacoeconomics
orphan drugs
rare diseases
cost-utility analysis
Rochtain Ar Líne:https://www.pharmacoeconomics.ru/jour/article/view/98
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla